News
Verimatrix Wins Top Prizes for Artificial Intelligence Security and Brand Growth in 2023 Cybersecurity Excellence Awards
Regulatory News:
Verimatrix, (Paris:VMX) (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced the company received two gold
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Poxel Announces Publication of Positive Phase 2 Results from Phase 2 NASH Trial (DESTINY-1) for PXL065 in Journal of Hepatology
Regulatory News:
POXEL SA (Euronext : POXEL – FR0012432516), clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology
Sensorion to Participate in the 6th Annual Bioprocessing Summit Europe
Regulatory News:
Sensorion (FR0012596468 – ALSEN) (Paris:ALSEN) a pioneering clinical-stage biotechnology company which specializes in gene therapies in the ear, is pleased to announce its
RUBIS: Information relating to the total number of voting rights and shares as of 28/02/2023
ROCTOOL: Freudenberg e-Power Systems sign a strategic agreement with Roctool for new Fuel Cell applications
Poxel Announces Publication in Kidney International of PXL770 Preclinical Results in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Regulatory News:
POXEL SA (Paris:POXEL) (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for serious chronic diseases with metabolic
Median Technologies to present new and breakthrough results for its iBiopsy® Lung Cancer Screening CADe/CADx Software as Medical Device at the European Congress of Radiology, taking place March 1-5 2023 in Vienna, Austria
Regulatory News:
Median Technologies (ALMDT:PA) today announces new and breakthrough results for its iBiopsy® Lung Cancer Screening (LCS) AI/ML tech-based CADe/CADx1 Software as Medical Device
Prodware: Business Accelerating in 2022: €188.3 M (+13.7%)
Median Technologies Announces Completion of the Q-Submission Phase with the FDA for its iBiopsy® Lung Cancer Screening CADe/CADx Software as Medical Device
Regulatory News:
Median Technologies (ALMDT) (Paris:ALMDT) announces today that the Company has received feedback from the United States Food and Drug Administration (FDA) regarding the
Freelance.com: Freelance.com generates over €800m in revenue in 2022
Sensorion Further Strengthens Leadership, Appoints David Lawrence as Chief Financial Officer
Regulatory News:
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within
Valbiotis veröffentlicht Brief an die Aktionäre und Finanzkommunikationskalender für 2023
Pflichtmitteilung:
Valbiotis (FR0013254851 – ALVAL, PEA / KMU-qualifiziert), ein kommerziell ausgerichtetes Forschungs- und Entwicklungsunternehmen, das sich auf wissenschaftliche Innovationen
EQS-News: Abivax publishes a prospectus in the context of its capital increase
Valbiotis Publishes Its Letter to Shareholders and Its 2023 Financial Calendar
Regulatory News:
Valbiotis (FR0013254851 – ALVAL, PEA / SME eligible), a commercially oriented Research and Development company committed to scientific innovation for preventing and combating
Median Technologies to Participate in the Cowen’s 43rd Annual Health Care Conference
Regulatory News:
Median Technologies (Paris:ALMDT), will be participating in the Cowen’s 43rd Annual Health Care Conference, taking place on March 6 – 8 ,2023, at the Boston Marriott Copley Place
Axway Software : Excellent 2022 Full-Year Results Supported by Record High Q4
Regulatory News:
Axway Software's (Paris:AXW) Board of Directors today conducted an in-depth review of the consolidated and annual financial statements2 for the year ended December 31, 2022. As a
BILENDI: 2022 : record revenues of €61.5 million (+39.5%)
Prodware: Phast Invest, holding company of the Prodware group has raised €20 M with Tikehau Capital and Prodware’s Historical Managers
Sensorion announces R&D Day focusing on its Gene Therapy programs
Regulatory News:
Sensorion, (Paris:ALSEN) (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company, specialising in the development of novel therapies to restore, treat and
Eutelsat Communications: First Half 2022-23 Results
Regulatory News:
The Board of Directors of Eutelsat Communications (ISIN: FR0010221234 / Euronext Paris: ETL), chaired by Dominique D’Hinnin, reviewed the financial results for the Half Year
Sartorius Stedim Biotech SA: Information on Document Availability
EQS-News: Abivax appoints Dr. Sheldon Sloan, M.D., as Chief Medical Officer
Pernod Ricard: H1 FY23 Sales and Results
Regulatory News:
Pernod Ricard (Paris:RI):
Press release - Paris, 16 February 2022
SALES
Sales for H1 FY23 reached €7,116m and grew +12% organically (+19% reported), with a favourable FX